A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The aim of this study was to compare the efficacy and tolerability of quetiapine and lithium monotherapy with that of placebo for a major depressive episode in bipolar disorder. METHOD: 802 patients with DSM-IV-defined bipolar disorder (499 bipolar I, 303 bipolar II) were randomly allocated to quetiapine 300 mg/d (n = 265), quetiapine 600 mg/d (n = 268), lithium 600 to 1800 mg/d (n = 136), or placebo (n = 133) for 8 weeks. Primary endpoint was the change in Montgomery-Asberg Depression Rating Scale (MADRS) total score. The study was conducted from August 2005 to May 2007. RESULTS: Mean MADRS total score change from baseline at week 8 was -15.4 for quetiapine 300 mg/d, -16.1 for quetiapine 600 mg/d, -13.6 for lithium, and -11.8 for placebo (P < .001 for both quetiapine doses, P = .123 for lithium, vs placebo). Quetiapine 600 mg/d was significantly more effective than lithium in improving MADRS total score at week 8 (P = .013). Quetiapine-treated (both doses), but not lithium-treated, patients showed significant improvements (P < .05) in MADRS response and remission rates, Hamilton Depression Rating Scale (HDRS), Clinical Global Impressions-Bipolar-Severity of Illness and -Change, and Hamilton Anxiety Rating Scale (HARS) scores at week 8 versus placebo. Both quetiapine doses were more effective than lithium at week 8 on the HDRS and HARS. The most common adverse events were somnolence, dry mouth, and dizziness with quetiapine (both doses) and nausea with lithium. CONCLUSIONS: Quetiapine (300 or 600 mg/d) was more effective than placebo for the treatment of episodes of acute depression in bipolar disorder. Lithium did not significantly differ from placebo on the main measures of efficacy. Both treatments were generally well tolerated. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00206141.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter finding must be reconciled with the fact that quetiapine beat placebo in only three of the five individual trials in patients with BDII, compared to all five in patients with BDI.253, 290, 438, 439, 440”
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 387
Review of Evidence for Use of Antidepressants in Bipolar Depression
McInerney, S. J., & Kennedy, S. H. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14r01653 · Cited by 31
Taiwan consensus of pharmacological treatment for bipolar disorder
Bai, Y., Chang, C.-J., Tsai, S., Chen, Y.-C., Hsiao, M., Li, C., Tu, P., Chang, S., Shen, W. W., & Su, T. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.06.013 · Cited by 29
Köhler, S., Gaus, S., & Bschor, T. (2014) · Pharmacopsychiatry · doi:10.1055/s-0033-1364004 · Cited by 29
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. N., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0274-7 · Cited by 30
Self-citationFisher, D. S., Handley, S. A., Flanagan, R. J., & Taylor, D. M. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182603f62 · Cited by 30
Curry, D. E., & Richards, B. L. (2022) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2022.180207 · Cited by 30
Relationship between placebo response rate and clinical trial outcome in bipolar depression
Iovieno, N., Nierenberg, A. A., Parkin, S. R., Kim, D. J. H., Walker, R. S. W., Fava, M., & Papakostas, G. I. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.12.016 · Cited by 27
Korean medication algorithm for bipolar disorder: Second revision
Shin, Y. C., Min, K. J., Yoon, B.-H., Kim, W. K., Jon, D., Seo, J. S., Woo, Y. S., Lee, J. G., & Bahk, W. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12062 · Cited by 27
REVIEW OF NUTRITIONAL SUPPLEMENTS FOR THE TREATMENT OF BIPOLAR DEPRESSION
Rakofsky, J. J., & Dunlop, B. W. (2013) · Depression and Anxiety · doi:10.1002/da.22220 · Cited by 29
Sánchez-Iglesias, S., García-Solaesa, V., Berrocal, B. G., Sánchez-Martín, A., Lorenzo-Romo, C., Martín-Pinto, T., Gaedigk, A., González‐Buitrago, J. M., & Isidoro‐García, M. (2016) · Medicine · doi:10.1097/md.0000000000002473 · Cited by 25
Walpoth, M., Kemmler, G., Grunze, H., Wei, U., Hörtnagl, C., Strau, R., Blasko, I., & Hausmann, A. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328356ac92 · Cited by 28
Predictive modeling for response to lithium and quetiapine in bipolar disorder
Kim, T. T., Dufour, S. C., Xu, C., Cohen, Z. D., Sylvia, L. G., Deckersbach, T., DeRubeis, R. J., & Nierenberg, A. A. (2019) · Bipolar Disorders · doi:10.1111/bdi.12752 · Cited by 25
Thronson, L. R., & Pagalilauan, G. L. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.001 · Cited by 27
Samalin, L., Guillaume, S., Courtet, P., Abbar, M., Lancrenon, S., & Llorca, P. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.10.001 · Cited by 23
Hwang, J. Y., Choi, J., Kang, S., Hwang, S. H., Kim, S. J., & Lee, Y. J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000699 · Cited by 23
The Presentation, Recognition and Management of Bipolar Depression in Primary Care
Cerimele, J. M., Chwastiak, L., Chan, Y.-F., Harrison, D. A., & Unützer, J. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2545-7 · Cited by 24
Loebel, A. D., Koblan, K. S., Tsai, J., Deng, L., Fava, M., KENT, J. M., & Hopkins, S. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.109 · Cited by 22
Bartoli, F., Dell’Osso, B. M., Crocamo, C., Fiorillo, A., Ketter, T. A., Suppes, T. M., Clerici, M., & Carrà, G. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.12.021 · Cited by 23
An overview of pharmacotherapy for bipolar I disorder
Morsel, A., Morrens, M., & Sabbe, B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1426746 · Cited by 24
Yaramala, S. R., McElroy, S. L., Geske, J. R., Winham, S. J., Gao, K., Reilly-Harrington, N. A., Ketter, T. A., Deckersbach, T., Kinrys, G., Kamali, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.025 · Cited by 23
Self-citationWang, D., & Osser, D. N. (2019) · Bipolar Disorders · doi:10.1111/bdi.12860 · Cited by 23
Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Rihmer, Z. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-8 · Cited by 23
A systematic review of the evidence for the treatment of acute depression in bipolar I disorder
Cerullo, M. A., & Strakowski, S. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000102 · Cited by 21
Moteshafi, H., & Stip, É. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.712682 · Cited by 20
Bipolar depression: clinically missed, pharmacologically mismanaged
Lloyd, L. C., Giaroli, G., Taylor, D. M., & Tracy, D. K. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311420752 · Cited by 21
Fisher, A. C., Sharpe, L., Anderson, J., Manicavasagar, V. L., & Juraskova, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200490 · Cited by 20
Kelly, T. (2019) · Bipolar Disorders · doi:10.1111/bdi.12753 · Cited by 21
The management of schizophrenia: focus on extended-release quetiapine fumarate
Peuskens, J. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3380 · Cited by 25
Gao, K., Yuan, C., Wu, R., Chen, J., Wang, Z., Fang, Y., & Calabrese, J. R. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1534-0 · Cited by 19
Yatham, L. N., Sossi, V., Ding, Y., Vafai, N. M., Arumugham, S. S., Dhanoa, T., Lam, R. W. M., Bond, D. J., & Puyat, J. H. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx066 · Cited by 21
Is there a ‘weight neutral’ second-generation antipsychotic for bipolar disorder?
Fang, F., Wang, Z., Wu, R., Calabrese, J. R., & Gao, K. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1276284 · Cited by 18
Antipsychotic Drugs and Dysregulated Glucose Homeostasis: A Systematic Review and Meta-Analysis
Smith, E. C. C., Agarwal, S. M., Panganiban, K. J., Maksyutynska, K., Monteiro, J., Lee, J., Prasad, F., Ji, A., Shah, D., Cavalier, S., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2240 · Cited by 23
Yoon, W., Shon, S., Hong, Y., Joo, Y. H., & Lee, J. S. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e290 · Cited by 18
Gao, K., Ayati, M., Koyutürk, M., Calabrese, J. R., Ganocy, S. J., Kaye, N. M., Lazarus, H. M., Christian, E., & Kaplan, D. R. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4424 · Cited by 21
Bipolar II Disorder: Understudied and Underdiagnosed
Swartz, H. A., & Suppes, T. M. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20230015 · Cited by 27
Machado‐Vieira, R., Zanetti, M. V., SOUSA, R. T. D., Soeiro‐de‐Souza, M. G., Moreno, R. A., Busatto, G. F., & Gattaz, W. F. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1864 · Cited by 19
Diagnosis and Management of Bipolar Disorder in Primary Care
Brenner, C. J., & Shyn, S. I. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.004 · Cited by 24
Riesenberg, R. A., Baldytcheva, I., & Datto, C. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.09.002 · Cited by 20
Gao, K., Ganocy, S. J., Conroy, C. M., Brownrigg, B., Serrano, M. B., & Calabrese, J. R. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4642-5 · Cited by 18
Bai, Y., Yang, H., Chen, G., & Gao, K. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001169 · Cited by 21
Intracellular Signaling Cascades in Bipolar Disorder
Jones, G. H., Rong, C., Shariq, A. S., Mishra, A. P., & Machado‐Vieira, R. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_157 · Cited by 19
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
El-Khalili, N. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s14369 · Cited by 19
The use of antipsychotics in preschoolers: A veto or a sensible last option?
Memarzia, J., Tracy, D. K., & Giaroli, G. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113519506 · Cited by 17
Gao, K., Goto, T., Yuan, C., Brownrigg, B., Conroy, C. M., Chan, P. K., Serrano, M. B., Ganocy, S. J., Fang, F., & Calabrese, J. R. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000927 · Cited by 18
Treatment of acute bipolar depression
Shen, Y. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_71_18 · Cited by 21
Management of Bipolar II Disorder
Wong, M. M. C. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85391 · Cited by 17
Poo, S. X. W., & Agius, M. (2014) · PubMed · Cited by 17
Okada, M., Fukuyama, K., & Motomura, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169103 · Cited by 17
Treatment outcomes of acute bipolar depressive episode with psychosis
Caldieraro, M. A., Dufour, S. C., Sylvia, L. G., Gao, K., Ketter, T. A., Bobo, W. V., Walsh, S. L., JANOS, J. A., Tohen, M. F., Reilly-Harrington, N. A., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22716 · Cited by 15
Self-citationCrapanzano, C., Damiani, S., & Guiot, C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001420 · Cited by 16
Cullen, C., Kappelmann, N., Umer, M., Abdolizadeh, A., Husain, M. O., Bonato, S., Sharma, G. K., Xue, S., Ortiz, A., Kloiber, S. M., et al. (2021) · Bipolar Disorders · doi:10.1111/bdi.13125 · Cited by 16
Quetiapine: A Pharmacoeconomic Review of its Use in Bipolar Disorder
Plosker, G. L. (2012) · PharmacoEconomics · doi:10.2165/11208500-000000000-00000 · Cited by 18
US Psychiatric Residents’ Treatment of Patients With Bipolar Disorder
Rakofsky, J. J., & Dunlop, B. W. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824857ad · Cited by 14
Effect of lithium on suicide and mortality in mood disorders: A systematic review
Börjesson, J., & Gøtzsche, P. C. (2019) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-190058 · Cited by 16
S3-Leitlinie Bipolare Störungen – 1. Update 2019: Was ist neu in der Pharmakotherapie?
Bschor, T., Baethge, C., Grunze, H., Lewitzka, U., Scherk, H., Severus, E., & Bauer, M. (2020) · Der Nervenarzt · doi:10.1007/s00115-019-00852-5 · Cited by 15
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2023) · doi:10.32920/14638581 · Cited by 13
The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression
Jones, G. H., Rong, C., Vecera, C. M., Gurguis, C. I., Chudal, R., Khairova, R. A., Leung, E., Ruiz, A. C., Shahani, L., Zanetti, M. V., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.025 · Cited by 12
Pharmacological treatment of bipolar depression
Vázquez, G. H., Tondo, L., Undurraga, J. P., Zaratiegui, R. M., Selle, V., & Baldessarini, R. J. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011460 · Cited by 13
Quetiapine monotherapy for bipolar depression
Janicak, P. G., & Rado, J. T. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.585461 · Cited by 12
Systematic Review of Recent Guidelines for Pharmacological Treatments of Bipolar Disorders in Adults
Hammett, S., & Youssef, N. A. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900409 · Cited by 14
Kishi, T., Ikuta, T., Sakuma, K., Matsuda, Y., & Iwata, N. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.020 · Cited by 13
Cai, L., Chen, G., Yang, H., & Bai, Y. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000449 · Cited by 11
Outpatient Triple Chronotherapy for Bipolar Depression: Case Report
GOTTLIEB, J. F., & TERMAN, M. (2012) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000419822.69914.8e · Cited by 11
Kowalczyk, E., Koziej, S., & Soroka, E. (2024) · Medical Science Monitor · doi:10.12659/msm.945412 · Cited by 16
Gao, K., Kaye, N. M., Ayati, M., Koyutürk, M., Calabrese, J. R., Christian, E., Lazarus, H. M., & Kaplan, D. R. (2023) · Medicina · doi:10.3390/medicina59010120 · Cited by 13
Zimmerman, M. A., Holst, C. G., Clark, H., Multach, M. D., Walsh, E. K., Rosenstein, L. K., & Gazarian, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0381-0 · Cited by 11
Kanba, S., Murasaki, M., Koyama, T., Takeuchi, M., Shimizu, Y., Arita, E., Kuroishi, K., Takeuchi, M., & Kamei, S. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2181-9 · Cited by 13
Updated perspectives on how and when lithium should be used in the treatment of mood disorders
RYBAKOWSKI, J. K., & Ferensztajn‐Rochowiak, E. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2181076 · Cited by 14
Kato, M., Masuda, T., Sano, F., & Kato, T. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.065 · Cited by 11
Pharmaceutical treatment of acute bipolar depression
Fountoulakis, K. Ν. (2010) · F1000 Medicine Reports · doi:10.3410/m2-47 · Cited by 12
Samalin, L., & Llorca, P. (2011) · L Encéphale · doi:10.1016/j.encep.2011.07.004 · Cited by 10
Álamo, C., Lopez-Munoz, F. J., & García‐García, P. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915741 · Cited by 10
Bipolar (Manic Depressive) Disorders
El‐Mallakh, R. S., & Bauer, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch49 · Cited by 10
Self-citationJeong, J.-H., Bahk, W.-M., Woo, Seo, Hong, Jon, Min, & Yoon (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41081 · Cited by 9
“3%, respectively, which were lower than those reported previously.(12,13,21) Although the current study was an openlabel observational study, the research protocol was not strict, and the study was conducted with a relatively short period of observation; these results suggest that quetiapine could be used safely for t…”
Korean Medication Algorithm for Bipolar Disorder 2010: Introduction
Minkyungjoon, Bahk, W., Yoon, B.-H., Kim, W. K., 김병수, Lee, J. G., Joo, Y. H., Seo, J., Lee, E. M., Ahn, Y.-M., et al. (2011) · 대한정신약물학회지 · Cited by 10
Pharmacotherapy of Acute Bipolar Depression in Adults: An Evidence Based Approach
Muneer, A. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.3.137 · Cited by 11
Treatment of bipolar depression
Musetti, L., Grande, C. D., Marazziti, D., & Dell’Osso, L. (2013) · CNS Spectrums · doi:10.1017/s1092852912001009 · Cited by 10
Köhler‐Forsberg, O., Sloth, K. H., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Tohen, M. F., Bowden, C. L., McInnis, M. G., Kocsis, J. H., Friedman, E. S., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114194 · Cited by 9
Self-citationQuetiapine extended release for the treatment of bipolar disorder
Samalin, L., Tremey, A., & Llorca, P. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.946407 · Cited by 9
New Approaches in the Treatment of Bipolar Depression
Saunders, K., & Goodwin, G. M. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_209 · Cited by 11
Missio, G., Moreno, D. H., Fernandes, F. D. S., Bio, D. S., Soeiro‐de‐Souza, M. G., dos Santos, D. R., David, D. P., Costa, L. F., Demétrio, F. N., & Moreno, R. A. (2013) · Trials · doi:10.1186/1745-6215-14-190 · Cited by 9
Pompili, M., Rihmer, Z., Gonda, X., Serafini, G., Sher, L., & Girardi, P. (2012) · PubMed · doi:10.1708/1178.13055 · Cited by 11
Bipolar Depression: An Evidence-Based Approach
Baldassano, C. F., Hosey, A., & Coello, J. A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0238-7 · Cited by 9
Assion, H.-J., Schweppe, A., Reinbold, H., & Frommberger, U. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0507-3 · Cited by 8
Ogasawara, M., Takeshima, M., Esaki, Y., Kaneko, Y., Utsumi, T., Aoki, Y., Watanabe, N., Suzuki, M., & Takaesu, Y. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12283 · Cited by 11
Erickson, B., Ehrie, J., Murray, S., Dougherty, R. J., Wainberg, M. L., Dixon, L. B., & Goldman, M. L. (2022) · Psychiatric Services · doi:10.1176/appi.ps.20220196 · Cited by 9
Weisler, R. H., & McIntyre, R. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846520 · Cited by 9
Hebbrecht, K., Morrens, M., Neels, H. M., Roosens, L., & Sabbe, B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1515911 · Cited by 9
Schaffer, A., McIntosh, D., Goldstein, B. I., Rector, N. A., McIntyre, R. S., Beaulieu, S., Swinson, R., & Yatham, L. N. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400103 · Cited by 7
Locklear, J. C., Alemayehu, B., Brody, R. S., Chavoshi, S., Tunceli, O., Kern, D. M., & Earley, W. R. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.005 · Cited by 7
Lithium et anticonvulsivants dans la dépression bipolaire
Samalin, L., Nourry, A., & Llorca, P. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70054-9 · Cited by 8
Resurrecting the discussion on neurotoxicity of lithium at therapeutic levels
Jha, A., Pai, N. M., Ganjekar, S., Desai, G., & Chaturvedi, S. K. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000341 · Cited by 7
Weisler, R. H., McIntyre, R. S., & Bauer, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846519 · Cited by 8
Self-citationThe Treatment of Bipolar Depression: Current Status and Future Perspectives
Jelen, L. A., & Young, A. H. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00200-x · Cited by 7
Self-citationPharmacogenetics to Prevent Maniac Affective Switching with Treatment for Bipolar Disorder: CYP2D6
Sánchez-Martín, A., Sánchez-Iglesias, S., Berrocal, B. G., Lorenzo, C., Gaedigk, A., & Isidoro‐García, M. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0105 · Cited by 7
Adherence to evidence-based treatment guidelines for bipolar depression in an inpatient setting
Freeland, K. N., Cogdill, B. R., Ross, C., Sullivan, C. O., Drayton, S. J., VandenBerg, A., Short, E. B., & Garrison, K. L. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/sp150023 · Cited by 6
Treatment of Acute and Maintenance Phase of Bipolar Depression
Erten, E. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27408 · Cited by 9
Lithium in bipolar depression: A review of the evidence
Riedinger, M. A., van der Wee, N. J. A., Giltay, E. J., & de Leeuw, M. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2881 · Cited by 8
Gao, K., Ayati, M., Kaye, N. M., Koyutürk, M., Calabrese, J. R., Christian, E., Lazarus, H. M., & Kaplan, D. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051491 · Cited by 6
Giouleka, S., Tsiona, E., Kapetanios, G., Zerva, C., Papazisis, G., Mamopoulos, A. M., Dagklis, T., & Tsakiridis, I. G. (2025) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001384 · Cited by 6
Metadata
- Authors
- Young, A. H., McElroy, S. L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., & EMBOLDEN I (Trial 001) Investigators
- Affiliations
- University of British Columbia (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-01-26
- Volume
- 71
- Issue
- 02
- Pages
- 150-162
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2028449820
- Cited by
- 390
- References
- 0
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 18 · 2023: 26 · 2022: 13 · 2021: 38 · 2020: 21 · 2019: 12 · 2018: 21 · 2017: 14 · 2016: 24 · 2015: 24 · 2014: 36 · 2013: 29 · 2012: 33
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- quetiapine, lithium, bipolar depression, bipolar disorder, atypical antipsychotics, monotherapy, acute depression, antidepressant efficacy, tolerability, sleepiness, nausea, depression remission, dose comparison, bipolar I disorder, bipolar II disorder, anxiety symptoms, mood stabilizers, placebo comparison, Montgomery-Asberg Depression Rating Scale, Hamilton Depression Rating Scale
- MeSH terms
- Quetiapine Fumarate, Adolescent, Adult, Aged, Antidepressive Agents, Bipolar Disorder, Dibenzothiazepines, Double-Blind Method, Female, Humans, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Treatment Outcome, Lithium Compounds, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.